A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes

• Status: Completed
• Trial end date: 2009-04-01

Summary

The purpose of this study is to assess safety and tolerability of AZD1656 after multiple repeated oral doses in patients with type 2 diabetes

• Phase: Phase 1

Details

• Lead Sponsor: AstraZeneca